Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse
- PMID: 6228595
Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse
Abstract
The immunologic potential of T lymphocytes and antigen-presenting cells (APC) from male and female mice were compared. Lymphocytes from female mice or from male mice that cannot produce and respond to testosterone (Tfm/y) were more reactive than male lymphocytes to alloantigens in MLR. Spleen cells from Tfm/y mice equipped with estrogen implants showed a higher responsiveness than control Tfm/y to alloantigens. The removal of suppressive adherent cells or the addition of T cell growth factor (TCGF) enhanced the proliferative activity of the cells in the MLR. The responsiveness of female cells to alloantigens, however, remained superior to that observed in male cells. Similarly, in the presence of TCGF, thymocytes from female mice react more effectively than male cells in MLR. In addition, Con A-stimulated spleen cells from female mice produce more interleukin 2 (IL 2) than do spleen cells from males or female mice treated with testosterone. Lymphocytes from immunized mice were tested for their ability to respond to soluble antigens (KLH and OVA) in vitro. Again, female immunocompetent cells respond more vigorously than male cells or cells originating in female mice with testosterone implants. APC from female spleen were more efficient than male APC in initiating a secondary response in primed lymphocytes from either males or female mice. Moreover, castration of male mice enhanced, and treatment of female mice with androgen reduced, the efficiency of antigen presentation. In conclusion, these data suggest that female cells are superior to male cells in immunologic functions that are known to be associated with reactions to and recognition of histocompatibility antigens, i.e., antigen presentation and MLR. Furthermore, our present data indicate that the differential reactivity of immunocytes between male and female mice depends on the hormonal balance of the animal.
Similar articles
-
Recognition and response to alloantigens in vivo. I. Negative and positive selection of MLR reactivity in murine peripheral blood lymphocytes to major histocompatibility complex and Mls antigens.J Immunol. 1984 Aug;133(2):606-15. J Immunol. 1984. PMID: 6234352
-
Suppression of cell-mediated immune responses after total lymphoid irradiation (TLI). I. Characterization of suppressor cells of the mixed lymphocyte reaction.J Immunol. 1984 Feb;132(2):971-8. J Immunol. 1984. PMID: 6140288
-
Studies on the capacity of intact cells and purified Ia from different B cell sources to function in antigen presentation to T cells.J Immunol. 1988 Jan 15;140(2):388-94. J Immunol. 1988. PMID: 2961812
-
Regulation of the immune response T-cell interactions.CRC Crit Rev Immunol. 1982 Feb;3(3):209-61. CRC Crit Rev Immunol. 1982. PMID: 6176399 Review. No abstract available.
-
Cellular immune response to non-MHC plasma membrane antigens.Transplant Proc. 1980 Sep;12(3 Suppl 1):135-40. Transplant Proc. 1980. PMID: 6159706 Review. No abstract available.
Cited by
-
Protocol for delivering proteins, peptides, and shRNAs via the intrathecal route in the experimental allergic encephalomyelitis mouse model.STAR Protoc. 2024 Sep 20;5(3):103219. doi: 10.1016/j.xpro.2024.103219. Epub 2024 Jul 27. STAR Protoc. 2024. PMID: 39068656 Free PMC article.
-
High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.Cancers (Basel). 2024 Mar 14;16(6):1152. doi: 10.3390/cancers16061152. Cancers (Basel). 2024. PMID: 38539486 Free PMC article.
-
Sex- and species-associated differences in complement-mediated immunity in humans and rhesus macaques.mBio. 2024 Mar 13;15(3):e0028224. doi: 10.1128/mbio.00282-24. Epub 2024 Feb 22. mBio. 2024. PMID: 38385704 Free PMC article.
-
A viral-specific CD4+ T cell response protects female mice from Coxsackievirus B3 infection.Front Immunol. 2024 Jan 11;14:1327384. doi: 10.3389/fimmu.2023.1327384. eCollection 2023. Front Immunol. 2024. PMID: 38274806 Free PMC article.
-
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective.Cancers (Basel). 2023 Dec 24;16(1):101. doi: 10.3390/cancers16010101. Cancers (Basel). 2023. PMID: 38201531 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials